In Brief: Clay Park recalls
This article was originally published in The Rose Sheet
Executive Summary
Clay Park recalls: Private-label manufacturer initiates Class III recalls (no adverse health effects likely) of 8 oz. bottles of facial soap for acne control due to subpotency, and 1.5 oz. tubes of 5% benzoyl peroxide gel because of product separation, according to FDA's April 5 Enforcement Report. The actions were initiated by letter March 10 and March 14, respectively. Approximately 2,199 units of the soap were distributed in California and Tennessee, and about 37,998 tubes of the benzoyl peroxide gel were distributed in 11 states and the West Indies. Clay Park also issued a Class III recall for a total of 29,456 .5 oz and 1 oz. bottles of medadyne liquid used to treat canker sores, fever blisters and cold sores by letter March 16. Manufactured under the Vetco and Dal-Med labels, the medadyne, distributed in New York, was recalled due to superpotency. All three recalls are ongoing...